FDA
-
-
-
-
-
-
-
MabVax Therapeutics Reports First Quarter 2017 Operational and Financial Results
-
-
-
-
-
-
-
MabVax Therapeutics (MBVX) Files IND for Novel Radioimmunotherapy Agent MVT-1075
-
328,610 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

